WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Available
Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, et al. (2011) WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. The European respiratory journal?: official journal of the European Society for Clinical Respiratory Physiology 38: 516-528 Available: http://www.ncbi.nlm.nih.gov/pubmed/21828024.
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Available
Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, et al. (2011) WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. The European respiratory journal?: official journal of the European Society for Clinical Respiratory Physiology 38: 516-528 Available: http://www.ncbi.nlm.nih.gov/pubmed/21828024.
Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China (n.d.). Available
Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China (n.d.). Available: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/71135719.1/iuatld/ijtld/2011/00000015/00000001/art00025/A63D11FDC5C11AC9135123367063CB2042F28FB615.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf. Accessed 26 October 2012.
8
84876702667
(Review)
Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, et al. (2013) Xpert ® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review).
Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008
doi:10.3760/cma.j.issn.0366-6999.2010.02.011
Wang H-X, Yue J, Han M, Yang J-H, Gao R-L, et al. (2010) Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008. Chin Med J; 123 (2): 184-187 doi:10.3760/cma.j.issn.0366-6999.2010.02.011.